Antimony: A metalloid hiding in industry and plastics
An antimony toxin test measures the amount of antimony (Sb), a metalloid used in flame retardants, brake pads, plastics manufacturing (as a catalyst in PET), and some electronics, in a human sample. Most clinical testing uses a spot urine sample analyzed by high‑sensitivity mass spectrometry (typically ICP‑MS) to quantify recent exposure. Results are reported as micrograms per liter (µg/L) and often “creatinine‑corrected” (µg/g creatinine) to account for urine concentration. Some labs also measure antimony in whole blood for very recent exposures, but urine is the most common biomonitoring matrix for population screening and occupational surveillance.
Why an antimony number is worth knowing
Why it matters: antimony levels reflect how much of this metal your body has encountered and is excreting—information that touches detoxification pathways, kidney handling, and, indirectly, immune and respiratory health. Testing gives objective data that can uncover hidden exposures from work, hobbies, or consumer products before they escalate into problems. Understanding your level helps you and your clinician judge whether additional follow‑up is warranted and how your body is adapting over time, supporting both short‑term symptom clarity and long‑term resilience.
Antimony can irritate airways, skin, and the GI tract, and certain forms are classified as possible carcinogens when inhaled over long periods. People may encounter it in industrial settings (textiles with flame retardants, metal smelting, brake and tire shops, plastics manufacturing), from dust at electronics recycling, or via beverages stored in hot conditions in certain plastic bottles. A test can reveal if your body is experiencing a recent exposure burden that might be contributing to cough, rashes, headaches, or fatigue, particularly when symptoms track with workdays or specific environments. Because antimony is primarily cleared through the kidneys into urine, measuring it can also hint at how efficiently you’re eliminating it.
Stepping back, testing is about measuring and managing risk early. Periodic monitoring can detect trends, show whether changes in environment are helping, and inform whether additional evaluation—like checking other metals, assessing kidney function, or reviewing respirator fit at work—would be useful. The goal isn’t to “pass or fail” but to place your biology on a map, see how it moves with real‑world changes, and guide smarter decisions for prevention and longevity, though more research is needed to refine individual risk thresholds.
Reading an antimony result
Your results are typically displayed as a numeric level compared to a reference range from the general population or occupational guidelines. “Normal” means you fall within what most people without known exposure show; “optimal” often refers to the lower end of population distributions associated with less exposure over time. Context matters. A single mildly elevated value can be meaningful if you have compatible symptoms, a relevant job, or a clear exposure scenario, and less meaningful if you were acutely exposed just before testing (e.g., sanding brake parts).
Higher levels may point to a recent or ongoing source, such as occupational dust, poorly ventilated workspaces, or heat‑exposed bottled drinks. Elevations don’t diagnose disease; they flag exposure. Patterns across time—repeat testing after typical workweeks versus vacations—can clarify whether the source is occupational, household, or intermittent. Creatinine‑corrected values help normalize for urine concentration, making trend comparisons more reliable.
What can skew an antimony reading
Lower or undetectable levels generally suggest minimal recent exposure and effective clearance. Balanced values tend to coincide with steady detoxification, good hydration, and limited environmental sources. Variation is expected—hydration status, timing of last shift, personal protective equipment use, and even a hot summer car releasing more compounds from plastics can influence a given sample.
What an antimony number can and can't tell you
The real strength of the antimony toxin test is pattern recognition over time. Interpreted alongside symptoms, job or hobby history, and related labs (other metals, kidney and liver markers, and inflammation), the results help build a cohesive story that supports preventive care, early detection of potential issues, and personalized strategies to reduce exposure when appropriate.
FAQs
An antimony toxin test measures the amount of antimony (a heavy metal) in a biological sample—most commonly urine or blood—to quantify recent or ongoing exposure; hair or nail samples may be used to assess longer‑term exposure.
These results report your personal antimony level (typically in micrograms per liter or gram) to help assess exposure and guide follow‑up; they are intended only to show your personal levels and do not by themselves diagnose health effects or predict symptoms.
Antimony is most commonly tested in urine (either a spot urine or a 24‑hour collection) and sometimes in blood for suspected very recent/acute exposures; hair or nails may be used for longer‑term exposure assessment but are less common.
Urine collection: follow the lab’s kit instructions—use the provided trace‑metal‑free container, discard the first morning void and then collect all urine for the next 24 hours (include the final morning void), keep the collection refrigerated, and return it promptly. Blood collection: a trained phlebotomist draws a sample into a trace‑metal‑free tube to avoid contamination. No special fasting is usually required; avoid contamination from topical products or environmental sources and follow any additional lab instructions.
Antimony test results indicate whether you have been exposed to higher-than-expected amounts of antimony and suggest the timing of that exposure: blood levels primarily reflect recent/ongoing exposure (hours–days), urine is useful for recent to short-term exposure and for monitoring removal from exposure (days–weeks), and hair or nails can reflect longer-term past exposure (weeks–months). A result within the laboratory’s reference range generally means no significant recent exposure, while elevated levels suggest recent or ongoing exposure that may require investigation and action.
Results must be interpreted with your clinician using your symptoms and exposure history—high antimony can affect the lungs, skin, gastrointestinal tract, heart, and nervous system—and trigger steps such as identifying and stopping the exposure source, medical monitoring, supportive care, and in severe poisoning, specialist treatment (e.g., chelation) where appropriate. Keep in mind labs use different reference ranges and there are limitations (timing of sampling, lab variability, and possible environmental contamination), so borderline or unexpected results often prompt repeat testing and occupational or public‑health evaluation rather than immediate conclusions about long‑term health.
Accuracy depends on timing of sampling, specimen choice and handling, laboratory quality (accreditation and quality control), limits of detection, and prior treatments such as chelation. Contamination during collection or storage and biological variability can cause false positives or negatives, so results must be interpreted in the context of exposure history, clinical findings, and, when needed, repeat or speciation testing by a reference lab.
If you have no known exposure or symptoms, routine antimony testing is generally unnecessary. Test when there is a clear reason — work-related exposure, accidental or environmental contamination, or symptoms suggestive of antimony toxicity — rather than on a fixed schedule for the general population.
For people with occupational or ongoing exposure, employers/clinicians commonly obtain a baseline test and then periodic monitoring (often annually, more frequently if exposure is high or changing). After a suspected acute exposure test immediately and repeat as advised by your clinician until levels fall; after removing a chronic source, retest weeks to a few months later to confirm decline. If you’re being treated (for example, with chelation), monitoring will be more frequent (weekly to monthly) per your treating clinician’s plan — follow occupational health or your provider’s recommendations for exact timing.
Yes. Antimony concentrations in biological samples can change relatively quickly after a change in exposure — typically over hours to days — because antimony is absorbed, distributed, and eliminated by the body. The rate of change depends on the chemical form of antimony, the route and magnitude of exposure, and individual factors such as kidney function.
Because levels reflect recent exposure, a single test may not distinguish acute from chronic exposure; timed or serial urine/blood samples and clinical context are often needed for accurate interpretation, so results should be discussed with a clinician or toxicologist.
References
- Cooper, R. G., & Harrison, A. P. (2009). The exposure to and health effects of antimony. Indian Journal of Occupational and Environmental Medicine, 13(1), 3-10. https://doi.org/10.4103/0019-5278.50716
- Schildroth, S., Osborne, G., Smith, A. R., Yip, C., Collins, C., Smith, M. T., Sandy, M. S., & Zhang, L. (2021). Occupational exposure to antimony trioxide: A risk assessment. Occupational and Environmental Medicine, 78(6), 396-402. https://doi.org/10.1136/oemed-2020-106980
- Agency for Toxic Substances and Disease Registry. (2019). ToxGuide for antimony and compounds. U.S. Department of Health and Human Services. https://www.atsdr.cdc.gov/toxguides/toxguide-23.pdf
- Tchounwou, P. B., Yedjou, C. G., Patlolla, A. K., & Sutton, D. J. (2012). Heavy metal toxicity and the environment. Experientia Supplementum, 101, 133-164. https://doi.org/10.1007/978-3-7643-8340-4_6
- Barr, D. B., Wilder, L. C., Caudill, S. P., Gonzalez, A. J., Needham, L. L., & Pirkle, J. L. (2005). Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environmental Health Perspectives, 113(2), 192-200. https://doi.org/10.1289/ehp.7337
- Jones, D. R., Jarrett, J. M., Tevis, D. S., Franklin, M., Mullinix, N. J., Wallon, K. L., Quarles, C. D., Jr., Caldwell, K. L., & Jones, R. L. (2017). Analysis of whole human blood for Pb, Cd, Hg, Se, and Mn by ICP-DRC-MS for biomonitoring and acute exposures. Talanta, 162, 114-122. https://doi.org/10.1016/j.talanta.2016.09.060






































.avif)

